FOLEY & LARDNER 13D and 13G filings for ReShape Lifesciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-15 3:34 pm Purchase | 2023-02-06 | 13D | ReShape Lifesciences Inc. RSLS | FOLEY & LARDNER | 2,308 27.700% | 2,308 (New Position) | Filing |